Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Pharmacological therapy for myocardial reperfusion injury.

Moukarbel GV, Ayoub CM, Abchee AB.

Curr Opin Pharmacol. 2004 Apr;4(2):147-53. Review.

PMID:
15063358
2.

Pharmacological possibilities for protection against myocardial reperfusion injury.

Wang QD, Pernow J, Sjöquist PO, Rydén L.

Cardiovasc Res. 2002 Jul;55(1):25-37. Review.

PMID:
12062706
3.
4.

Orphan targets for reperfusion injury.

Inserte J, Barrabés JA, Hernando V, Garcia-Dorado D.

Cardiovasc Res. 2009 Jul 15;83(2):169-78. doi: 10.1093/cvr/cvp109. Epub 2009 Apr 7. Review.

PMID:
19351740
5.

Sodium-hydrogen exchange inhibition and beta-blockade additively decrease infarct size.

Wang P, Zaragoza C, Holman W.

Ann Thorac Surg. 2007 Mar;83(3):1121-7.

PMID:
17307470
6.
7.

Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.

Dirksen MT, Laarman GJ, Simoons ML, Duncker DJ.

Cardiovasc Res. 2007 Jun 1;74(3):343-55. Epub 2007 Jan 23. Review.

PMID:
17306241
8.

Na+/H+ exchanger inhibition at the onset of reperfusion decreases myocardial infarct size: role of reactive oxygen species.

Fantinelli JC, Cingolani HE, Mosca SM.

Cardiovasc Pathol. 2006 Jul-Aug;15(4):179-84.

PMID:
16844548
9.

[Beneficial effects of diltiazem on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].

Zhao JL, Yang YJ, You SJ, Jing ZC, Wu YJ, Yang WX, Meng L, Tian Y, Chen JL, Gao RL, Chen ZJ.

Zhonghua Yi Xue Za Zhi. 2005 Mar 16;85(10):679-83. Chinese.

PMID:
15932731
10.

[Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].

Lupi Herrera E, Gaspar J, González Pacheco H, Martínez Sánchez C, Pastelín Hernández G, Luna Ortiz P, Chávez Cosio E.

Arch Cardiol Mex. 2006 Oct-Dec;76 Suppl 4:S76-101. Review. Spanish.

PMID:
17469337
11.

Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options.

Maxwell SR, Lip GY.

Int J Cardiol. 1997 Jan 31;58(2):95-117. Review.

PMID:
9049675
12.

Effect of acidic reperfusion on prolongation of intracellular acidosis and myocardial salvage.

Inserte J, Barba I, Hernando V, Abellán A, Ruiz-Meana M, Rodríguez-Sinovas A, Garcia-Dorado D.

Cardiovasc Res. 2008 Mar 1;77(4):782-90. Epub 2007 Dec 4.

PMID:
18056767
13.

Role of adenosine as adjunctive therapy in acute myocardial infarction.

Forman MB, Stone GW, Jackson EK.

Cardiovasc Drug Rev. 2006 Summer;24(2):116-47. Review.

PMID:
16961725
14.

Pharmacological pre- and post- conditioning agents: reperfusion-injury of the heart revisited.

Andreadou I, Iliodromitis EK, Koufaki M, Kremastinos DT.

Mini Rev Med Chem. 2008 Aug;8(9):952-9. Review.

PMID:
18691153
15.

Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation.

Bulhak A, Roy J, Hedin U, Sjöquist PO, Pernow J.

Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3158-63. Epub 2007 Feb 23.

16.

Pharmacological strategies to contend against myocardial reperfusion damage: diverse chemicals for multiple targets.

Correa F, Martínez-Abundis E, Hernández-Reséndiz S, García N, Buelna-Chontal M, Arreguín F, Zazueta C.

Curr Med Chem. 2010;17(21):2261-73.

PMID:
20459379
17.

The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size.

Kristo G, Yoshimura Y, Ferraris SP, Jahania SA, Mentzer RM Jr, Lasley RD.

J Am Coll Surg. 2004 Oct;199(4):586-94.

PMID:
15454144
18.

Comparison of the protective effect of N-acetylcysteine by different treatments on rat myocardial ischemia-reperfusion injury.

Abe M, Takiguchi Y, Ichimaru S, Tsuchiya K, Wada K.

J Pharmacol Sci. 2008 Apr;106(4):571-7. Epub 2008 Apr 3.

19.

Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts.

Argaud L, Gateau-Roesch O, Augeul L, Couture-Lepetit E, Loufouat J, Gomez L, Robert D, Ovize M.

Am J Physiol Heart Circ Physiol. 2008 Jan;294(1):H386-91. Epub 2007 Oct 19.

20.

Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.

Petrosillo G, Colantuono G, Moro N, Ruggiero FM, Tiravanti E, Di Venosa N, Fiore T, Paradies G.

Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1487-93. doi: 10.1152/ajpheart.00163.2009. Epub 2009 Aug 14.

Supplemental Content

Support Center